Fever News and Research

RSS

The Big Catch-Up reaches millions of children with life-saving vaccines

The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.

24 Apr 2026

Rising rotavirus cases highlight importance of childhood vaccination

With a rising number of rotavirus cases being reported across the country and in New Jersey this spring, experts from Hackensack Meridian Children's Health are urging parents to ensure their children are vaccinated against this common and potentially severe illness.

21 Apr 2026

Millions of Americans with hepatitis C still remain untreated, analysis reveals

Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals.

21 Apr 2026

New handbook aims to improve pandemic modeling and decision making

As the COVID-19 pandemic wreaked havoc and lives were at stake, the advice experts gave to decision-makers became indispensable.

17 Apr 2026

Childhood flu infection leaves lasting immune imprint

A study reveals how childhood flu infections impact long-term mortality risk, highlighting implications for vaccination and future outbreak management.

17 Apr 2026

AI analyzes Reddit posts to find underreported GLP-1 side effects

By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents.

10 Apr 2026

New monoclonal antibody shows promise for preventing Lyme disease

A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the prevention of Lyme disease in the U.S. was well tolerated and showed lasting serum concentrations in participants, according to data presented by Mark Klempner, MD, at the World Vaccine Congress 2026 in Washington D.C.

8 Apr 2026

State-run insurance plans for foster kids leave some of them without doctors

Ollie Super has moved in and out of cancer treatment since she was diagnosed with neuroblastoma as a toddler in foster care. Now 8, the second grader is dealing with it again. Her cancer came back late last year.

2 Apr 2026

Digoxin found safe to use in young patients with rheumatic heart disease

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with those who received a placebo, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

30 Mar 2026

Ticks can survive for up to three weeks inside homes

It's fairly common for members of the public to ask bug experts if ticks that hitchhike into a house on people or dogs can actually survive indoors for any length of time.

27 Mar 2026

Redesigned lipid nanoparticles improve mRNA delivery to lymph nodes

Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to steer the particles toward lymph nodes while reducing off-target delivery to the liver.

24 Mar 2026

Study highlights neurological and psychiatric impacts of long COVID

Nearly three years after the SARS-CoV-2 pandemic was declared over, conservative estimates suggest that between 80 million and 400 million people worldwide have long COVID.

23 Mar 2026

Climate change drives dengue outbreaks through extreme weather events

Diseases historically absent from the United States have been showing up in Florida, Texas, California and other U.S. states in recent years.

17 Mar 2026

Modified lipid nanoparticles boost mRNA vaccines while reducing side effects

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise.

17 Mar 2026

New risk models improve food safety guidelines for pregnant individuals

Listeria is the third-leading cause of death among bacterial foodborne pathogens in the U.S. and pregnant individuals bear a disproportionate share of that burden.

17 Mar 2026

Swedish study reveals COVID-19 may increase glandular fever risk

Even individuals who did not become seriously ill with COVID-19 may have developed a weakened immune system that could lead to serious illnesses in the future.

17 Mar 2026

Targeting two influenza proteins may reduce viral transmission

A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from replicating inside an infected host or prevent the virus from transmitting to others.

13 Mar 2026

The 0.05 EU/mg breakthrough: How Sino Biological ProPure™ is redefining the Ultra-Low Endotoxin standard

When we discuss bacterial infections, we often think of exotoxins—those soluble proteins actively secreted by bacteria—while overlooking endotoxins, which are more insidious but equally dangerous.

From Sino Biological Inc. 12 Mar 2026

Japan's famous matcha could reduce sneezing in people with nasal allergies

There's now another reason to love Japan's famous matcha: a study in mice suggests that the green tea powder could reduce the need to sneeze in people with nasal allergies.

11 Mar 2026

More kids are in ERs for tooth pain. Trump cuts and RFK Jr.’s anti-fluoride fight aren’t helping.

Eight-year-old Jonah woke up one May morning with a swollen face and a toothache. He refused the pain medication that his mom, Geneva Reynolds, tried to give him. He didn't sleep or eat and cried constantly.

10 Mar 2026